Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercepharma.com
FiercePharma
Get the latest updates from FiercePharma directly as they happen.
Follow now 402 followers
Latest posts
Last updated about 3 hours ago
Eliminating KRAS: Why targeted protein degraders could redefine what’s possible in cancer
about 3 hours ago
How targeted protein degraders could eliminate KRAS and redefine cancer care –...
Real-World Evidence in the AI Era: What You Can Unlock Depends on What You Build On
about 3 hours ago
The differentiator isn't algorithms; it's data quality. Discover the two critical bottlenecks...
AbbVie, GSK race up patient reputation leaderboard in the UK
about 3 hours ago
AbbVie and GSK have surged up the rankings of the pharma companies...
Tyra creates awareness day with patient advocates to shine light on a rare cancer
about 4 hours ago
Tyra Biosciences has partnered with a patient advocacy group to create an...
AbbVie plots 85 summer layoffs tied to Allergan aesthetics unit in California
about 5 hours ago
The layoffs at AbbVie's Irvine, California, location will take effect on July...
Europe's CHMP gives thumbs up to AZ's breast cancer drug after thumbs down from FDA adcomm
about 5 hours ago
Less than a month after an FDA advisory committee recommended rejection of...
AstraZeneca, Daiichi beat Gilead to first-line TNBC with FDA nod for Datroway
about 5 hours ago
A three-way battle among TROP2 ADCs in first-line triple-negative breast cancer is...
Novartis, AbbVie plan summer layoffs on opposite coasts
about 5 hours ago
AbbVie's 85 layoffs are tied to its Allergan Aesthetics headquarters in California...
Designing an agentic, future‑ready tech roadmap for emerging pharma
about 6 hours ago
JR Raelin of SynOx Therapeutics and Krishna GS of ZS discuss how...
Fierce Pharma Asia—Merck-Kelun ADC’s triple wins; Tools in China licensing deals; Takeda’s $885M antitrust loss
about 8 hours ago
Merck & Co. and Kelun-Biotech's sac-TMT is on fire this week with...
Roche narrowly edges out AstraZeneca for the top-rated oncology MSL team: survey
about 15 hours ago
Roche/Genentech and AstraZeneca have the best-performing medical science liaison (MSL) teams in...
ASCO: Merck, Kelun's sac-TMT ADC combo beats Keytruda by 65% on progression in first-line lung cancer
about 24 hours ago
According to an abstract released ahead of the ASCO 2026 annual meeting...